Abstract:IMPORTANCE Premenstrual disorders (PMDs), characterized by affective symptoms before menses, significantly impact women who are suffering. Current diagnostic tools are time-consuming and challenging in practice, resulting in delay in detection and treatment. There is an urgent need to identify objective and easily accessible measures to streamline the diagnostic process for PMDs. Objectives To investigate the menstrual fluctuation of wearable device-based real-time heart rate variability (HRV) through menstrual cycles and its associations with premenstrual disorders (PMD) symptoms. Design, Setting, and Participants We conducted a prospective study of female participants nested from the Care of Premenstrual Emotion Cohort. Exposure outcome and measures Daily HRV metrics (SDNN, rMSSD, LF, HF, and LF/HF) were estimated from consecutive RR-intervals (RRI) collected by the Huawei Fitness Tracker 6 Pro at 5-minute intervals over 1-2 menstrual cycles and averaged on records during 03:00-05:00 a.m. PMD symptoms were assessed with the Daily Record of Severity of Problems on a daily basis. HRV variability across cycles was described using descriptive statistics and splines, while associations between HRV metrics and PMD symptoms were estimated using a mixed-effect model. Results In total, 193 participants (with 68 prospectively confirmed PMDs) were included, with measures from 293 menstrual cycles. In both women with and without PMDs, SDNN, rMSSD, and HF decreased before menses and increased afterwards; the increase trends were more pronounced in women without PMDs. During the week before or after menses, levels of these HRV metrics were inversely associated with PMD symptoms among women with PMDs (e.g., rMSSD, postmenstrual week, β = -0.036 per SD, 95% CI: -0.048 to -0.065), whereas null association was noted for those without PMDs (β = -0.001, 95% CI -0.011 to 0.009; P-for-difference < 0.001). The association was particularly stronger with affective symptoms than with physiological symptoms, and more pronounced during the premenstrual week among women with premenstrual dysphoric disorder compared with those with premenstrual syndrome. Conclusion and Relevance Our findings suggest that wearable device-estimated HRV metrics fluctuate across menstrual cycles, with varying strengths of association with PMD symptoms between individuals with and without PMDs, which may aid future diagnostic process for PMDs.

Biomarker development for menstrual cycle affective change: the need for greater temporal, mechanistic, and phenotypic specificity

Dimensional Affective Sensitivity to Hormones across the Menstrual Cycle (DASH-MC): A transdiagnostic framework for ovarian steroid influences on psychopathology

Neuroactive steroid hormone trajectories across the menstrual cycle in premenstrual dysphoric disorder (PMDD): the PHASE study

Stress, mood, and cortisol during daily life in women with Premenstrual Dysphoric Disorder (PMDD)

Peripheral Blood Mononuclear Cell Expression of Cation-Chloride Cotransporter (CCC) Genes in Premenstrual Dysphoric Disorder (PMDD) across the Menstrual Cycle—A Preliminary Study

Importance of Daily Sex Hormone Measurements Within the Menstrual Cycle for Fertility Estimates in Cyclical Shifts Studies

Menstrual cycle rhythmicity: metabolic patterns in healthy women

Associations of luteal phase changes in vagally mediated heart rate variability with premenstrual emotional changes

Wearable-Measured Heart Rate Variability and Premenstrual Disorder Symptoms across Menstrual Cycle

Cumulative stressor exposure predicts menstrual cycle affective changes in a transdiagnostic outpatient sample with past-month suicidal ideation

Menstrual cycle related depressive symptoms and their diurnal fluctuations – an ambulatory assessment study

Changes in Psychotropic Drug Concentrations Across the Menstrual Cycle: A Pilot Study

Neuroimaging the Menstrual Cycle and Premenstrual Dysphoric Disorder

Menstrual cycle effects on amygdala reactivity to emotional stimulation in premenstrual dysphoric disorder

How to study the menstrual cycle: Practical tools and recommendations

The Effect of Menstrual Cycle Phases on Approach–Avoidance Behaviors in Women: Evidence from Conscious and Unconscious Processes

Neuroactive steroid levels are elevated in the follicular phase and predict premenstrual depression and anxiety symptom severity in women with menstrually related mood disorder

Premenstrual syndrome is associated with differences in heart rate variability and attentional control throughout the menstrual cycle: A pilot study

Ways of coping with premenstrual change: development and validation of a premenstrual coping measure

The impact of the menstrual cycle on diurnal endocrine rhythms and depressive symptoms from adolescence to adulthood

Emotion-induced brain activation across the menstrual cycle in individuals with premenstrual dysphoric disorder and associations to serum levels of progesterone-derived neurosteroids